Human breast cancer cell-mediated bone collagen degradation requires plasminogen activation and matrix metalloproteinase activity
<p>Abstract</p> <p>Background</p> <p>Breast cancer cells frequently metastasize to the skeleton and induce extensive bone destruction. Cancer cells produce proteinases, including matrix metalloproteinases (MMPs) and the plasminogen activator system (PAS) which promote i...
Main Authors: | Hill Peter A, Morgan Hayley |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-02-01
|
Series: | Cancer Cell International |
Online Access: | http://www.cancerci.com/content/5/1/1 |
Similar Items
-
Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer
by: Lim Kyu, et al.
Published: (2006-08-01) -
The roles of the plasminogen activator and matrix metalloproteinase systems in ovulation and corpus luteum formation
by: Bodén, Ida
Published: (2004) -
The role of matrix metalloproteinases in leukocyte migration and collagen degradation in tuberculosis
by: Sathyamoorthy, Tarangini
Published: (2013) -
Matrix Metalloproteinase Mediated Type I Collagen Degradation — An Independent Risk Factor for Mortality in Women
by: K. Dragsbæk, et al.
Published: (2015-07-01) -
Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis <it>ex vivo</it> rat model
by: Veidal Sanne Skovgård, et al.
Published: (2012-12-01)